Tennakoon R, Bily T, Hasan F, Syal S, Voigt A, Balci T
Mol Ther Nucleic Acids. 2025; 36(1):102442.
PMID: 39897579
PMC: 11787650.
DOI: 10.1016/j.omtn.2024.102442.
Heilmann R, Pfalzer A, Bichell T, Terala A, Campbell A, Taatjes D
Ther Adv Rare Dis. 2024; 5:26330040241290252.
PMID: 39619418
PMC: 11605767.
DOI: 10.1177/26330040241290252.
Awawdeh A, Tapia A, Alshawi S, Dawodu O, Gaier S, Specht C
Nucleic Acids Res. 2024; 52(22):14244-14259.
PMID: 39558163
PMC: 11662663.
DOI: 10.1093/nar/gkae1048.
Wilhelm S, Kakadia J, Beharry A, Kenana R, Hoffman K, ODonoghue P
Nucleic Acids Res. 2024; 52(22):14043-14060.
PMID: 39530218
PMC: 11662652.
DOI: 10.1093/nar/gkae996.
Yamada K, Hariharan V, Caiazzi J, Miller R, Ferguson C, Sapp E
Nat Biotechnol. 2024; .
PMID: 39090305
DOI: 10.1038/s41587-024-02336-7.
Dysregulation of tRNA methylation in cancer: Mechanisms and targeting therapeutic strategies.
Yuan W, Zhang R, Lyu H, Xiao S, Guo D, Zhang Q
Cell Death Discov. 2024; 10(1):327.
PMID: 39019857
PMC: 11254935.
DOI: 10.1038/s41420-024-02097-x.
Tuning tRNAs for improved translation.
Weiss J, Decker J, Bolano A, Krahn N
Front Genet. 2024; 15:1436860.
PMID: 38983271
PMC: 11231383.
DOI: 10.3389/fgene.2024.1436860.
Therapeutic Nonsense Suppression Modalities: From Small Molecules to Nucleic Acid-Based Approaches.
Morais P, Zhang R, Yu Y
Biomedicines. 2024; 12(6).
PMID: 38927491
PMC: 11201248.
DOI: 10.3390/biomedicines12061284.
Suppressor tRNA in gene therapy.
Ruan J, Yu X, Xu H, Cui W, Zhang K, Liu C
Sci China Life Sci. 2024; 67(10):2120-2131.
PMID: 38926247
DOI: 10.1007/s11427-024-2613-y.
Mechanisms and Delivery of tRNA Therapeutics.
Ward C, Beharry A, Tennakoon R, Rozik P, Wilhelm S, Heinemann I
Chem Rev. 2024; 124(12):7976-8008.
PMID: 38801719
PMC: 11212642.
DOI: 10.1021/acs.chemrev.4c00142.
Suppressor tRNAs at the interface of genetic code expansion and medicine.
Awawdeh A, Radecki A, Vargas-Rodriguez O
Front Genet. 2024; 15:1420331.
PMID: 38798701
PMC: 11116698.
DOI: 10.3389/fgene.2024.1420331.
Assembling the RNA therapeutics toolbox.
Teng M, Xia Z, Lo N, Daud K, He H
Med Rev (2021). 2024; 4(2):110-128.
PMID: 38680684
PMC: 11046573.
DOI: 10.1515/mr-2023-0062.
Mistranslating the genetic code with leucine in yeast and mammalian cells.
Davey-Young J, Hasan F, Tennakoon R, Rozik P, Moore H, Hall P
RNA Biol. 2024; 21(1):1-23.
PMID: 38629491
PMC: 11028032.
DOI: 10.1080/15476286.2024.2340297.
tRNA therapeutics for genetic diseases.
Coller J, Ignatova Z
Nat Rev Drug Discov. 2023; 23(2):108-125.
PMID: 38049504
DOI: 10.1038/s41573-023-00829-9.
Stimuli-Responsive Nanotechnology for RNA Delivery.
Zhou H, Chen D, Hu C, Hong X, Shi J, Xiao Y
Adv Sci (Weinh). 2023; 10(36):e2303597.
PMID: 37915127
PMC: 10754096.
DOI: 10.1002/advs.202303597.
tRNA renovatio: Rebirth through fragmentation.
Kuhle B, Chen Q, Schimmel P
Mol Cell. 2023; 83(22):3953-3971.
PMID: 37802077
PMC: 10841463.
DOI: 10.1016/j.molcel.2023.09.016.
Emerging roles of tRNA-derived small RNAs in cancer biology.
Lee S, Kim J, Valdmanis P, Kim H
Exp Mol Med. 2023; 55(7):1293-1304.
PMID: 37430089
PMC: 10393972.
DOI: 10.1038/s12276-023-01038-5.
Genetic Interaction of tRNA-Dependent Mistranslation with Fused in Sarcoma Protein Aggregates.
Lant J, Hasan F, Briggs J, Heinemann I, ODonoghue P
Genes (Basel). 2023; 14(2).
PMID: 36833445
PMC: 9956149.
DOI: 10.3390/genes14020518.
Gene, RNA, and ASO-based therapeutic approaches in Cystic Fibrosis.
Allaire N, Griesenbach U, Kerem B, Lueck J, Stanleigh N, Oren Y
J Cyst Fibros. 2023; 22 Suppl 1:S39-S44.
PMID: 36658041
PMC: 10012168.
DOI: 10.1016/j.jcf.2022.12.016.
Noncoding RNAs Emerging as Drugs or Drug Targets: Their Chemical Modification, Bio-Conjugation and Intracellular Regulation.
Wang J, Tian T, Li X, Zhang Y
Molecules. 2022; 27(19).
PMID: 36235253
PMC: 9573214.
DOI: 10.3390/molecules27196717.
